The risks associated with BAP1-related germline RCC are not well known because ccRCC with somatic BAP1 mutations are highly malignant, but early intervention and close follow-up may be necessary [26,27]. This evidence concerns the gene BAP1 and nonpapillary renal cell carcinoma.